Analysis of human bone sialoprotein in normal and pathological tissues using a monoclonal antibody (BSP 1.2 mab)

Connective Tissue Research

Volumn 45, Issue 1, 2004, Pages 60-71

  Cogan, Gabrielle ^a   Bansal, Ansal K ^a   Ibrahim, Sarwat ^a   Zhu, Baoqian ^a   Goldberg, Harvey A ^b   Ganss, Bernard ^a   Cheifetz, Sela ^a   Armbruster, Franz P ^c   Sodek, Jaro ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c IMMUNDIAGNOSTIK AG   (Germany)

Author keywords

Bone; Bone sialoprotein; Breast cancer; Immunostaining; Monoclonal antibody

Indexed keywords

AMINO ACID; EPITOPE; GLYCOPROTEIN; MONOCLONAL ANTIBODY; SIALOPROTEIN; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; BACTERIUM; BONE MATRIX; BONE METASTASIS; BREAST TUMOR; CALVARIA; CANCER CELL CULTURE; CANCER PATIENT; CONTROLLED STUDY; EMBRYO; EMBRYONAL TISSUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LYMPHOMA; OSTEOBLAST; OSTEOCYTE; OSTEOSARCOMA CELL; PATHOPHYSIOLOGY; PLACENTA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SWINE; TIBIA; TROPHOBLAST;

ANTIBODIES, MONOCLONAL; BONE AND BONES; BONE DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; EMBRYO; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; SIALOGLYCOPROTEINS; STAINING AND LABELING;

MAMMALIA; SUS SCROFA;

EID: 1842833422     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.1080/03008200490278151     Document Type: Article

References (36)

1. Harris, N.L., Rattray, K.R., Tye, C.E., Underhill, T.M., Somerman, M.J., D'Erico, J.A., Chambers, A.F., Hunter, G.K., and Goldberg, H.A. (2000). Functional analysis of bone sialoprotein: Identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis. Bone 27:795-802.
2. Goldberg, H.A., Warner, K.J., Li, M.C., and Hunter, G.K. (2001). Binding of bone sialoprotein, osteopontin and synthetic polypeptides to hydroxyapatite. Connect. Tiss. Res. 42:25-37.
3. Oldberg, Å., Franzén, A., and Heinegärd, D. (1988). The primary structure of a cell-binding bone sialoprotein. J. Biol. Chem. 263:19430-19432.
4. Hunter, G.K., and Goldberg, H.A. (1993). Nucleation of hydroxyapatite by bone sialoprotein. Proc. Natl. Acad. Sci. USA 90:8562-8565.
5. Chen, J., Shapiro, H.S., Wrana, J.L., Reimers, S., Heersche, J.N.M., and Sodek, J. (1991). Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 11:133-143.
6. Chen, J., Shapiro, H.S., and Sodek, J. (1992). Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues. J. Bone Miner. Res. 7:987-997.
7. Chen, J., McCulloch, C.A.G., and Sodek, J. (1993). Bone sialoprotein in developing porcine dental tissues: Cellular expression and comparison of tissue localization with osteopontin and osteonectin. Arch. Oral Biol. 38:241-249.
8. Chen, J., Sasaguri, K., Sodek, J., Aufdemorte, T.B., Jiang, H., and Thomas, H.F. (1998). Enamel epithelium expresses bone sialoprotein (BSP). Eur. J. Oral Sci. 106 Suppl 1:331-336.
9. Yao, K.-L., Todescan, R. Jr., and Sodek, J. (1994). Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J. Bone Miner. Res. 9:231-240.
10. Sodek, J., Chen, J.K., Kasugai, S., Nagata, T., Zhang, Q., McKee, M.D., and Nanci, A. (1992). Elucidating the functions of bone sialoprotein and osteopontin in bone formation. In Chemistry and Biology of Mineralized Tissues, H. Slavkin and P. Price (eds), pp. 297-306 (Elsevier Science Ltd., London, UK).
11. Ganss, B., Kim, R.H., and Sodek, J. (1999). Bone sialoprotein. Crit. Revs. Oral Biol. Med. 10:79-98.
12. Bellahcène, A., Merville, M.-P., and Castronovo, V. (1994). Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res. 54:2833-2836.
13. Gillespie, M.T., Thomas, R.J., Pu, Z.Y., Zhou, H., Martin, T.J., and Findlay, D.M. (1997). Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers. Int. J. Cancer 73:812-815.
14. Bellahcène, A., Kroll, M., Liebens, F., and Castronovo, V. (1996). Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J. Bone Miner. Res. 11:665-670.
15. Bellahcène, A., and Castronovo, V. (1997). Expression of bone matrix proteins in human breast cancer: Potential roles in microcalcification formation and in the genesis of bone metastases. Bull. Cancer 84:17-24.
16. Waltregny, D., Bellahcène, A., de Leval, X., Florkin, B., Weidle, U., and Castronovo, V. (2000). Increased expression of bone sialoprotein in bone metastases compared with visceral metastases inhuman breast and prostate cancers. J. Bone Miner Res. 15:834-843.
17. Ibrahim, T., Leong, I., Sanchez-Sweatman, O., Khokha, R., Sodek, J., Tenenbaum, H.C., Ganss, B., and Cheifetz, S. (2000). Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin. Exper. Metastasis 18:253-260.
18. Bellahcène, A., Maloujahmoum, N., Fisher, L.W., Pastorino, H., Tagliabue, E., Ménard, S., and Castronovo, V. (1997). Expression of bone sialoprotein in human lung cancer. Calcif. Tiss. Int. 61:183-188.
19. Waltregny, D., Bellahcène, A., Van Riet, I., Fisher, L.W., Young, M., Fernandez, P., Dewe, W., de Leval, J., and Castronovo, V. (1998). Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J. Natl. Cancer Inst. 90:1000-1008.
20. Withold, W., Armbruster, F.P., Karmatschek, M., and Reinauer, H. (1997). Bone sialoprotein in serum of patients with malignant bone-diseases. Clin. Chem. 43:85-91.
21. Stork, S., Stork, C., Angerer, P., Kothny, W., Schmitt, P., Wehr, U., von Schacky, C., and Rambeck, W. (2000). Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: A randomized 1-year study. Osteoporosis Int. 11:790-796.
22. Woitge, H.W., Pecherstorfer, M., Horn, E., Keck, A.-V., Diel, I.J., Bayer, P., Ludwig, H., Ziegler, R., and Seibel, M.J. (2001). Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. Br. J. Cancer 84:344-351.
23. Seibel, M.J., Woitge, H.W., Pecherstorfer, M., Karmatschek, M., Horn, E., Ludwig, H., Armbruster, F.P., and Ziegler, R. (1996). Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease. J. Clin. Endocrinol. Metab. 81:3289-3294.
24. Diel, I.J., Solomayer, E.-F., Seibel, M.J., Pfeilschifter, J., Maisenbacher, H., Gollan, C., Pecherstorfer, M., Conradi, R., Kehr, G., Boehm, E., Armbruster, F.P., and Bastert, G. (1999). Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin. Cancer Res. 5:3914-3919.
25. Fedarko, N.S., Fohr, B., Robey, P.G., Young, M.F., and Fisher, L.W. (2000). Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J. Biol. Chem. 275:16666-166672.
26. Fedarko, N.S., Jain, A., Karadag, A., van Eman, M.R., and Fisher, L.W. (2001). Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin. Cancer Res. 7:4060-4066.
27. Zhang, Q., Domenicucci, C., Goldberg, H.A., Wrana, J.L., and Sodek, J. (1990). Characterization of fetal porcine bone sialoproteins: Secreted phosphoprotein 1 (SPP1, osteopontin), bone sialoprotein, and a 23 kDa glycoprotein. Demonstration that the 23 kDa glycoprotein is derived from the carboxy-terminus of SPP1. J. Biol. Chem. 265:7583-7589.
28. Tye, C.E., Rattray, K.R., Warner, K.J., Gordon, J.A.R., Sodek, J., Hanter, G.K., and Goldberg, H.A. (2003). Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J. Biol. Chem. 278:7949-7955.
29. Kasugai, S., Nagata, T., and Sodek, J. (1992). Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro. J. Cell Physiol. 152:467-477.
30. Zhu, X.L., Ganss, B., Goldberg, H.A., and Sodek, J. (2001). Synthesis and processing of bone sialoproteins during de novo bone formation in vitro. Biochem. Cell. Biol. 79:737-746.
31. Bellahcène, A., Antoine, N., Clausse, N., Tagliabue, E., Fisher, L.W., Kerr, J.M., Jares, P., and Castronovo, V. (1996c). Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels. Lab. Invest. 75:203-210.
32. Ecarot-Charrier, B., Bouchard, F., and Dellove, C. (1989). Bone sialo-protein II synthesized by cultured osteoblasts contains tyrosine sulfate. J. Biol. Chem. 264:20049-20053.
33. Bianco, P., Fisher, L.W., Young, M.F., Termine, J.D., and Robey, P.G. (1991). Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tiss. Int. 49:421-426.
34. Chenu, C., and Delmas, P.D. (1992). Platelets contribute to circulating levels of bone sialoprotein in human. Cancer Res. 54:2823-2826.
35. Castronovo, V., and Bellahcéne, A. (1998). Evidence that breast cancer associated microcalifications are mineralized malignant cells. Int.J. Oncol. 12:305-308.
36. Sharp, J.A., Sung, V., Slavin, J., Thompson, E.W., and Henderson, M.A. (1999). Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab. Invest. 79:869-877.